DJIA 17,698.18 -77.94 -0.44%
NASDAQ 4,880.23 -20.66 -0.42%
S&P 500 2,059.69 -8.20 -0.40%
market minute promo

Incyte Corp (NASDAQ: INCY)

89.44 -2.22 (-2.42%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

INCY $89.44 -2.42%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $92.30
Previous Close $91.66
Daily Range $87.42 - $92.48
52-Week Range $40.30 - $99.00
Market Cap $15.4B
P/E Ratio -316.07
Dividend (Yield) $0.00 (0.0%)
Volume 1,227,089
Average Daily Volume 1,226,932
Current FY EPS -$0.26




Drug Makers

Incyte Corp (INCY) Description

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Website:

News & Commentary Rss Feed

Why It's Not Too Late to Buy Agenus, Inc. Stock

Small-cap biotech Agenus has seen its share price roar higher since acquiring some highly prized assets in immuno-oncology. Here's why this stock could push even higher going forward.

Watch Out: Barbarians At The Gate For Incyte (INCY)

Pharmacyclics, BioMarin, And Incyte: A Quick Screen

Incyte (INCY) Is Today's Post-Market Loser Stock

Novartis' Jakavi Gets EC Approval for Polycythemia Vera - Analyst Blog

US Stock Futures Edge Lower Ahead Of Housing Starts Data

Cell Therapeutics: Pacritinib's Targeted Market Opportunity

CTI Biopharma Discloses More Data on Myelofibrosis Drug in SEC Filing

Commit To Purchase Incyte Corporation At $67.50, Earn 7% Annualized Using Options

Why CTI BioPharma Corp Is Surging Higher Today

Positive results for CTI BioPharma Corp's myelofibrosis drug sent shares higher.

See More INCY News...

INCY's Top Competitors

INCY $89.44 (-2.42%)
Current stock: INCY
AMGN $157.10 (-1.72%)
Current stock: AMGN
GILD $97.72 (-0.42%)
Current stock: GILD
CELG $114.57 (-0.62%)
Current stock: CELG